Elisabeth M. Oehrlein, PhD, MS, research is focused on qualitative and quantitative methods to collect and apply data about patient and caregiver experiences, priorities, and unmet needs to guide decisions across drug development. Before founding AppliedPX, she served on the National Health Council (NHC) senior leadership team. At the NHC, Dr. Oehrlein led numerous initiatives, including developing the Patient Experience Mapping Toolbox. She has spoken widely on the topic of patient-centered research, including invited presentations at the National Academy of Sciences and briefings to the Rare Disease Congressional Caucus. She is a contributing author and editor of the CIOMS report, Patient involvement in the development, regulation and safe use of medicines. Dr. Oehrlein is an active member of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), where she has held leadership roles in the Patient-Centered and Real-World Evidence Special Interest Groups and is faculty for the short course “An Introduction to Patient-Focused Medical Product Development.” She has published widely in medical, economic, and health policy journals and is an Associate Editor of Value in Health.
Dr. Oehrlein holds a BA from Franklin & Marshall College, an MS in Epidemiology from the University of Maryland School of Medicine’s Department of Epidemiology and Human Genetics, and a Ph.D. in Pharmaceutical Health Services Research from the University of Maryland School of Pharmacy.
